#news #biotech Celgene executive blames Receptos for ozanimod filing fail

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Celgene executive blames Receptos for ozanimod filing fail .A top Celgene executive has pinned the blame for the botched ozanimod filing on Receptos. Nadim Ahmed said Celgene’s arm’s-length relationship with the biotech it bought for $7.2 billion three years ago led to a substandard filing and embarrassing refusal-to-file notice. 

from FierceBiotech: Biotech https://ift.tt/2LOMmvN